A translational end-run for a rare, genetically enigmatic tumor.
Hackett
Christopher S
CS
Biomedical Sciences Graduate Program and Department of Neurology, University of California, San Francisco, CA, USA.
Weiss
William A
WA
D045744:Cell Line, Tumor; D002626:Chemistry, Pharmaceutical / Q000379:methods; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000494:pharmacology; D015972:Gene Expression Regulation, Neoplastic; D005821:Genetic Techniques; D006801:Humans; D008495:Medical Oncology / Q000379:methods; D009154:Mutation; D009447:Neuroblastoma / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D034622:RNA Interference; D015398:Signal Transduction
D004791:Enzyme Inhibitors